Literature DB >> 7535926

Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.

G Scholz1, M P Felder, H Hanafusa.   

Abstract

We have previously reported that a serine(threonine) protein kinase that phosphorylates histone H1 in vitro is activated by tyrosine phosphorylation in v-Src-transformed rat 3Y1 fibroblasts. We now refer to this kinase as YRP kinase, for tyrosine-regulated protein kinase. Since YRP kinase may play a role in mediating the growth-stimulatory and morphology-altering effects of v-Src, we have further examined the signal transduction involved in the activation of YRP kinase. Although YRP kinase is constitutively activated in fibroblasts transformed by v-Src, activation of protein kinase C was also found to lead to activation of YRP kinase. Activation of YRP kinase by protein kinase C was found to be potentiated by vanadate treatment or overexpression of c-Src. The activation of YRP kinase by v-Src, however, does not appear to be mediated by protein kinase C, suggesting that YRP kinase can be activated by two separate signal transduction pathways. Transformation of fibroblasts by v-Ras or v-Mil did not result in activation of YRP kinase, indicating that the MAP kinase pathway does not mediate the activation of YRP kinase by v-Src or protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535926      PMCID: PMC42264          DOI: 10.1073/pnas.92.7.2592

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Protein kinase C phosphorylates pp60src at a novel site.

Authors:  K L Gould; J R Woodgett; J A Cooper; J E Buss; D Shalloway; T Hunter
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

3.  Induction of an unusual type of shared phosphorylation in human and avian cells by tumor-promoting phorbol esters or transformation.

Authors:  J Sagara; K M Yamada; T Kakunaga
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

4.  Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases.

Authors:  R Hirst; A Horwitz; C Buck; L Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters.

Authors:  R Jove; B J Mayer; H Iba; D Laugier; F Poirier; G Calothy; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  Activation of the transforming potential of p60c-src by a single amino acid change.

Authors:  J B Levy; H Iba; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation.

Authors:  F R Cross; H Hanafusa
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

8.  Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells.

Authors:  A Rodriguez-Pena; E Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

9.  1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets.

Authors:  S Kawamoto; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  1 in total

1.  Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src.

Authors:  G Scholz; C Martinerie; B Perbal; H Hanafusa
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.